Methylphenidate-induced autoimmune hepatitis

Digestive Diseases and Sciences

Volumn 52, Issue 2, 2007, Pages 594-597

  Lewis, Jason J ^a   Iezzoni, Julia C ^a   Berg, Carl L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Autoimmune hepatitis; Liver transplantation; Methylphenidate

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHETAMINE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLOSPORIN; DEXAMPHETAMINE; FOSINOPRIL; HEMOGLOBIN; HYDROCHLOROTHIAZIDE; METHYLPHENIDATE; OMEPRAZOLE; PREDNISONE; VENLAFAXINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELL INFILTRATION; CONCENTRATION LOSS; CREATININE BLOOD LEVEL; DEPRESSION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EOSINOPHIL; HEMATOCRIT; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; LEUKOCYTE COUNT; LIVER BIOPSY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MALE; PLASMA CELL; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ALANINE TRANSAMINASE; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; HEPATITIS, AUTOIMMUNE; HEPATITIS, TOXIC; HUMANS; LIVER TRANSPLANTATION; MALE; METHYLPHENIDATE; MIDDLE AGED; PREDNISOLONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846796305     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9525-2     Document Type: Article

References (14)

1. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54-66
2. Lewis JH, Zimmerman H (1998) Drug induced autoimmune liver disease. In: Krawitt EL, Wiesner RH, Nishioka M (eds) Autoimmune liver disease, 2nd ed. Elsevier, Amsterdam, pp 627-649
3. Nietsch HH, et al. (2000) Minocycline-induced hepatitis. Am J Gastroenterol 95:2993-2994
4. Alla, V, et al. (2006) Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 40:757-761
5. Sterling MJ, Kane M, Grace N (1996) Pemoline-induced autoimmune hepatitis. Am J Gastroenterol 91(10):2233-2234
6. Challman TD, Lipsky J (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75(7):711-721
7. Bader GM, Hawley J, Short D (1998) Venlafaxine augmentation with methylphenidate for treatment refractory depression: A case report. J Clin Psychopharm 18(3):255-256
8. Plutchik L, Snyder S, Drooker M, et al. (1998) Methylphenidate in post-liver transplant patients. Psychosomatics 39:118-123
9. Kalant, H (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. Can Med Assoc J 165(7):917-928
10. Maurer HH, et al. (2004) Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophenone types; a synopsis. Ther Drug Monit 26(2):127-131
11. Jones AL, Simpson K (1999) Review article: Mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13(2):129-133
12. Lyseng-Williamson KA, Keating GM (2002) Extended-release methylphenidate. Drugs 62(15):2251-2259
13. Goodman CR (1972) Hepatotoxicity due to methylphenidate hydrochloride. NY State J Med 72(18):2339-2340
14. Mehta H, Murray B, Loludice T (1984) Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride. J Clin Gastroenterol 6:149-151